Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(13%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
2
25%
Ph not_applicable
6
75%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
unknown1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (25.0%)
N/A6 (75.0%)

Trials by Status

completed563%
unknown113%
recruiting113%
terminated113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8